Home
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma

Clinical trial condition

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Explore clinical trials studying Precursor Cell Lymphoblastic Leukemia-Lymphoma. Study availability and eligibility vary by location and protocol.

1,800 public trials 303 recruiting studies

Refine in advanced search Browse all conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma trial results

Active, Not Recruiting

Cardiovascular Reserve Evaluation in Survivors of Transplant, CREST Study

NCT04537871

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Blood Protein Disorders, +32 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Active, Not Recruiting

Study of Brexucabtagene Autoleucel Plus Dasatinib in Adults With Acute Lymphoblastic Leukemia

NCT05993949

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Stanford University Palo Alto, California, United States

View Trial Details

Active, Not Recruiting

Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclax

NCT05192889

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Active, Not Recruiting

Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia and Persistent/Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm

NCT02159495

Conditions: Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Adult Acute Lymphoblastic Leukemia, +35 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Active, Not Recruiting

A French Protocol for the Treatment of Acute Lymphoblastic Leukemia (ALL) in Children and Adolescents

NCT02716233

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: CHU Amiens, France

CHU Angers, France

CHRU Besançon, France

CHU Bordeaux, France

View all 28 locations

View Trial Details

Active, Not Recruiting

A Pediatric and Young Adult Trial of Genetically Modified T Cells Directed Against CD19 for Relapsed/Refractory CD19+ Leukemia

NCT02028455

Conditions: CD19+ Acute Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Children's Hospital Los Angeles Los Angeles, California, United States

Children's Hospital Oakland Oakland, California, United States

Seattle Children's Hospital Seattle, Washington, United States

View Trial Details

Active, Not Recruiting

Goal Management Training for Adult Survivors of Childhood Leukemia and Non-Hodgkins Lymphoma With Neurocognitive Sequelae

NCT04541056

Conditions: Childhood Acute Lymphoblastic Leukemia, Childhood Acute Myeloid Leukemia, Childhood Non-Hodgkin Lymphoma, +11 more
Locations: Oslo University Hospital - Rikshospitalet Oslo, Norway

St. Olavs Hospital Trondheim, Norway

Department of Psychology, Norwegian University of Science and Technology (NTNU) Trondheim, Norway

View Trial Details

Active, Not Recruiting

Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation

NCT02790515

Conditions: Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Bone Marrow Diseases, +32 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Active, Not Recruiting

Muscle Dysfunction in Patients With Haematological Diseases

NCT05150561

Conditions: Acute Lymphoid Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +15 more
Locations: Rigshospitalet Copenhagen, Denmark

View Trial Details

Active, Not Recruiting

Venetoclax in Addition to Blinatumomab in Adult Patients With Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL)

NCT05182385

Conditions: ALL, Recurrent, Adult, Disease Attributes, Hematologic Diseases, +15 more
Locations: Universitätsklinikum Tübingen Tübingen, Baden-Wurttemberg, Germany

Universitätsklinikum Ulm Ulm, Baden-Wurttemberg, Germany

University Hospital of Frankfurt (Main) Frankfurt am Main, Hesse, Germany

Universitätsklinikum Dresden Dresden, Saxony, Germany

View all 17 locations

View Trial Details

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Precursor Cell Lymphoblastic Leukemia-Lymphoma trial results

Related conditions